These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12383528)

  • 21. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST; Sharma G; Kalish RB; Chervenak FA
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
    Pandya PP; Snijders RJ; Johnson SP; De Lourdes Brizot M; Nicolaides KH
    Br J Obstet Gynaecol; 1995 Dec; 102(12):957-62. PubMed ID: 8652486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
    Noble PL; Abraha HD; Snijders RJ; Sherwood R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):390-5. PubMed ID: 8903913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic.
    Dhaifalah I; Májek O
    Ceska Gynekol; 2012 Feb; 77(1):39-51. PubMed ID: 22536640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
    Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
    Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
    Tercanli S; Holzgreve W; Batukan C; Gerber A; Ermis H; Miny P
    Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's syndrome.
    Michailidis GD; Spencer K; Economides DL
    BJOG; 2001 Oct; 108(10):1047-52. PubMed ID: 11702836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study.
    Cicero S; Curcio P; Papageorghiou A; Sonek J; Nicolaides K
    Lancet; 2001 Nov; 358(9294):1665-7. PubMed ID: 11728540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between increased nuchal translucency and second trimester cardiac echogenic foci.
    Prefumo F; Presti F; Thilaganathan B; Carvalho JS
    Obstet Gynecol; 2003 May; 101(5 Pt 1):899-904. PubMed ID: 12738147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuchal translucency: an ultrasound marker for fetal chromosomal abnormalities.
    Acácio GL; Barini R; Pinto Júnior W; Ximenes RL; Pettersen H; Faria M
    Sao Paulo Med J; 2001 Jan; 119(1):19-23. PubMed ID: 11175621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.